206 related articles for article (PubMed ID: 31452866)
1. Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum.
Chen DQ; Cao G; Zhao H; Chen L; Yang T; Wang M; Vaziri ND; Guo Y; Zhao YY
Ther Adv Chronic Dis; 2019; 10():2040622319869116. PubMed ID: 31452866
[TBL] [Abstract][Full Text] [Related]
2. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
[TBL] [Abstract][Full Text] [Related]
3. Novel RAS Inhibitors Poricoic Acid ZG and Poricoic Acid ZH Attenuate Renal Fibrosis via a Wnt/β-Catenin Pathway and Targeted Phosphorylation of smad3 Signaling.
Wang M; Chen DQ; Chen L; Liu D; Zhao H; Zhang ZH; Vaziri ND; Guo Y; Zhao YY; Cao G
J Agric Food Chem; 2018 Feb; 66(8):1828-1842. PubMed ID: 29383936
[TBL] [Abstract][Full Text] [Related]
4. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
5. Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosis
Chen DQ; Wu XQ; Chen L; Hu HH; Wang YN; Zhao YY
Ther Adv Chronic Dis; 2020; 11():2040622320962648. PubMed ID: 33062239
[TBL] [Abstract][Full Text] [Related]
6. Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis.
Wang M; Chen DQ; Chen L; Cao G; Zhao H; Liu D; Vaziri ND; Guo Y; Zhao YY
Br J Pharmacol; 2018 Jul; 175(13):2689-2708. PubMed ID: 29679507
[TBL] [Abstract][Full Text] [Related]
7. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
[TBL] [Abstract][Full Text] [Related]
8. Poricoic acid A suppresses TGF-β1-induced renal fibrosis and proliferation via the PDGF-C, Smad3 and MAPK pathways.
Li Q; Ming Y; Jia H; Wang G
Exp Ther Med; 2021 Apr; 21(4):289. PubMed ID: 33717232
[TBL] [Abstract][Full Text] [Related]
9. WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling.
Hoi S; Tsuchiya H; Itaba N; Suzuki K; Oka H; Morimoto M; Takata T; Isomoto H; Shiota G
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):940-946. PubMed ID: 32012313
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-catenin signaling pathway contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury and is possibly related to the transforming growth factorβ1/Smad3 signaling pathway.
Zhang G; Ge M; Han Z; Wang S; Yin J; Peng L; Xu F; Zhang Q; Dai Z; Xie L; Li Y; Si J; Ma K
Biomed Pharmacother; 2019 Feb; 110():420-430. PubMed ID: 30530044
[TBL] [Abstract][Full Text] [Related]
11. Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis.
Chen DQ; Wang YN; Vaziri ND; Chen L; Hu HH; Zhao YY
Phytomedicine; 2020 Jul; 72():153232. PubMed ID: 32460034
[TBL] [Abstract][Full Text] [Related]
12. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine-2,3-Dioxygenase Activates Wnt/β-Catenin Inducing Kidney Fibrosis after Acute Kidney Injury.
Pan B; Zhang H; Hong Y; Ma M; Wan X; Cao C
Gerontology; 2021; 67(5):611-619. PubMed ID: 34130288
[TBL] [Abstract][Full Text] [Related]
14. Association of β-catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF-β1.
Tian X; Zhang J; Tan TK; Lyons JG; Zhao H; Niu B; Lee SR; Tsatralis T; Zhao Y; Wang Y; Cao Q; Wang C; Wang Y; Lee VW; Kahn M; Zheng G; Harris DC
J Cell Sci; 2013 Jan; 126(Pt 1):67-76. PubMed ID: 23203799
[TBL] [Abstract][Full Text] [Related]
15. A potential link between fibroblast growth factor-23 and the progression of AKI to CKD.
Lu Y; Xu S; Tang R; Han C; Zheng C
BMC Nephrol; 2023 Apr; 24(1):87. PubMed ID: 37016338
[TBL] [Abstract][Full Text] [Related]
16. Novel poricoic acids attenuate renal fibrosis through regulating redox signalling and aryl hydrocarbon receptor activation.
Wang M; Hu HH; Chen YY; Chen L; Wu XQ; Zhao YY
Phytomedicine; 2020 Dec; 79():153323. PubMed ID: 32920287
[TBL] [Abstract][Full Text] [Related]
17. Sustained Activation of Wnt/β-Catenin Signaling Drives AKI to CKD Progression.
Xiao L; Zhou D; Tan RJ; Fu H; Zhou L; Hou FF; Liu Y
J Am Soc Nephrol; 2016 Jun; 27(6):1727-40. PubMed ID: 26453613
[TBL] [Abstract][Full Text] [Related]
18. IL-6 accelerates renal fibrosis after acute kidney injury via DNMT1-dependent FOXO3a methylation and activation of Wnt/β-catenin pathway.
Guo X; Zhu Y; Sun Y; Li X
Int Immunopharmacol; 2022 Aug; 109():108746. PubMed ID: 35569307
[TBL] [Abstract][Full Text] [Related]
19. Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway.
Dou F; Ding Y; Wang C; Duan J; Wang W; Xu H; Zhao X; Wang J; Wen A
Biochem Pharmacol; 2020 Oct; 180():114079. PubMed ID: 32511988
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of miR-155 Ameliorates Acute Kidney Injury by Apoptosis Involving the Regulation on TCF4/Wnt/β-Catenin Pathway.
Zhang XB; Chen X; Li DJ; Qi GN; Dai YQ; Gu J; Chen MQ; Hu S; Liu ZY; Yang ZM
Nephron; 2019; 143(2):135-147. PubMed ID: 31216555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
